FDA's Breakthrough Designation is Working, Says Report

Article

Pharmaceutical Executive

April 21, 2016.

The good news about FDA’s breakthrough drug initiative is that it actually appears to be accelerating clinical development of highly promising new therapies, according to recent analysis by Friends of Cancer Research (FOCR) .

Read Jill Wechsler's view in Applied Clinical Trials.

Recent Videos
Matthew Yelovich, Cleary Gottlieb, Theranos Case
Jennifer Kyle, Condor
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
James Foster
Ash Shehata
Related Content
Abid Rahman

Google Gemini, AI Commercialization in Pharma and More: Q&A with Abid Rahman, SVP, Innovation, EVERSANA

Mike Hollan
April 3rd 2025
Article

Rahman discusses Google Gemini and what it could mean to the future of pharma commercialization and content development.

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Miranda Schmalfuhs
February 10th 2025
Podcast

Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.

Mitja Alexander Linss, Karger Publishers

The Evolution of Healthcare Communication: Bridging the HCP-Patient Divide

Mitja Alexander Linss
March 28th 2025
Article

Key trends in healthcare communication to build trust between healthcare providers and their patients.

Don Sortor

Protecting the Pipeline: Secure Communications Strategies to Thwart Espionage and Safeguard Sensitive Information and Intellectual Property

Don Sortor
March 18th 2025
Article

In an era where business-critical information is exchanged instantly, unsecured communication channels are a significant risk.

High Impact

High Impact

Mike Hennessy Jr.
March 14th 2025
Article

As coverage in Pharmaceutical Executive’s March issue reinforces, AI's connections and permutations are seemingly touching all parts of the industry—and only growing.

Foster and Markovitz

Pre-Launch Prep for Emerging Biopharmas: Data First, Then the Rest

Todd Foster;Yair Markovits
March 13th 2025
Article

Making early commercial data and analytics decisions for launch cen future-proof their data management.